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Review Article
Evolution of Foetal echocardiography as a screening tool for
prenatal diagnosis of congenital heart disease
Nuruddin Badruddin. Mohammed,1 Anandakumar Chinnaiya2

Maternal and Foetal Medicine Unit, Department of Obstetrics & Gynaecology, Division of Women and Child Health, Aga Khan University Hospital,
Karachi, Pakistan,1 Antenatal Diagnostic Center and Well Women Clinic, Camden Medical Center, One Orchard Boulevard, Singapore.2

Abstract

Congenital cardiac anomalies are the most common
anomalies, with an estimated incidence of about 4-13 per
1000 live births. Proper perinatal and neonatal management
is dependent upon accurate prenatal diagnosis.
Approximately 10% of foetuses with cardiac abnormalities
have identified risk factors; hence, most of the anomalies
occur in pregnancies without prenatal risk factors. Foetal
echocardiography allows for prenatal diagnosis of
congenital heart disease and serves as a routine screening
tool for congenital heart defects. Advanced technology, has
not only allowed more accurate and early detection of
cardiac abnormalities but has also improved the care and
outcome of selected foetuses with severe cardiac
malformations or arrhythmias. It can also identify patients
for in-utero cardiac interventions. Prenatal diagnosis of
congenital heart disease has allowed for better counseling
and preparation of families regarding the expected prenatal
development of the foetus as well as the anticipated
postnatal management strategy and prognosis.
Keywords: Foetal Echocardiography, Prenatal Diagnosis,
Congenital heart disease, In-utero cardiac intervention.

Introduction

Over the past two decades, imaging has become the
principle diagnostic tool in the prenatal detection of Foetal
malformations. The introduction of real-time imaging has
made in-utero evaluation of Foetal heart structure and
function available as well. With a live birth incidence of 0.41.3%,1,2 congenital heart disease (CHD) comprises the most
common form of major birth defect, being six times more
common than chromosomal abnormalities and four times
more common than neural tube defects.3 It accounts for
approximately 20% of neonatal deaths and 50% of infant
deaths and is seen four to five times more frequently in
stillbirths.3,4 As a group, these defects account for significant
neonatal morbidity and mortality, resulting in an economic
burden on the health care system and a financial and
emotional burden on the involved families.5

The purpose of this review article is to highlight:
1. Methods available for Foetal echocardiography
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2. Examination of the Foetal heart

3. Foetal echocardiography as a screening tool used for inutero diagnosis of abnormal Foetal cardiovascular structure
and physiology;
4. Role of early Foetal echocardiography.

Methods available for Foetal echocardiography:

The examination of the Foetal heart utilizes B-mode
(two-dimensional echocardiography), M-mode, spectral
Doppler (pulsed wave and continuous wave) and colour
Doppler flow mapping (two-dimensional Doppler
echocardiography). These technical advances in sonographic
instrumentation and analysis have allowed for in-depth
anatomic and physiologic study of the Foetal heart both in its
normal and malformed state.

The most important aspect of the echocardiographic
examination is two-dimensional echocardiography which,
when performed trans-abdominally allows the exact
diagnosis of most cardiac abnormalities due to the high
spatial and temporal resolution of modern real-time
ultrasound machines in the demonstration of cardiac
structures.6 High frequency probes improve the likelihood of
detecting subtle defects.7
M-mode echocardiography has the advantage of
superior temporal and spatial resolution and thus facilitates the
exact measurement of cardiac walls, valves and chambers at a
defined point in the cardiac cycle. However, over a period of
time the B-mode has superseded the M-mode in terms of the
spatial and temporal resolution and has improved to a great
degree as to allow precise measurements and bypass the
shortcomings of M-mode echocardiography, namely the
complexity in obtaining the exact measuring position of the
cursor and control during measurements. M-mode tracings of
the atria and ventricles can delineate the Foetal rhythm and
therefore, is used for the differential diagnosis of Foetal
arrhythmias. In particular, a simultaneous record of Doppler
waveform at the superior vena cava and the ascending aorta
has become an important and useful method of assessing the
interval between atrial and ventricular contractions.8,9
Identifying congenital complete heart block prenatally can
prepare families and health care providers for the need for
delivery at a tertiary center should the foetus require
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temporary or permanent pacing after delivery. Beta stimulants
and steroids have been reported as effective transplacental
treatments for Foetal atrioventricular block.10-12

After two-dimensional echocardiography, colour
coded echocardiography is the most important examination
method in the diagnosis of cardiac anomalies. Simultaneous
display of blood flow within the two-dimensional picture
enhances the identification of vessels and allows a rapid
overview for cardiac flow anomalies. Moreover, it increases
the sensitivity of echocardiographic examinations as jets in
regurgitation and valvular stenosis can be detected. The
differentiation of complex cardiac abnormalities, especially
those with obstructions of the outflow tracts is made easier
and in selected cases analysis of the blood flow patterns
allows for more differentiated assessment of prognosis.13

Examination of the Foetal heart:

Cardiac examination planes utilized in-utero are
similar to those used in the postnatal period, although the
airless lungs and less reflective ribs provide better access to
the Foetal heart than after birth. This approach can be used
from the 13th week of gestation onwards. A complete and
thorough Foetal cardiovascular examination should include a
segmental evaluation of the arrangement of the thoracoabdominal organs and the entire Foetal heart and great
vessels. Not infrequently, however, the operator must be
flexible because Foetal position may alter the order in which
the standard views are obtained. In addition to an
unfavourable position, other factors that may affect the study
and limit visualization include maternal obesity and
oligohydramnios.14
Yoo et al.15 described a sequential segmental approach
for the evaluation of Foetal heart using six basic sonographic
views:

1. The transverse view of the Foetal upper abdomen is
obtained to determine the arrangement of the abdominal
organs, which, in most cases, provides the important clues to
the determination of the atrial arrangement.
2. The four-chamber view is obtained to evaluate the
atrio-ventricular junctions.

3. The views of the left and right ventricular outflow
tracts are obtained to evaluate the ventricular-arterial
junctions.
4. The three-vessel view and the aortic arch view are
obtained for the evaluation of the arrangement and size of the
great arteries, which provides additional clues to the
diagnosis of the abnormalities involving the ventriculararterial junctions and the great arteries.

At the beginning, the operator determines the position
of the foetus and establishes abdominal situs by identifying
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the right and left sides of the trunk. In the normal situation,
the stomach should be visualized in the left side of the
abdomen. Once the Foetal orientation has been established,
the transducer can be tilted from its view of the abdominal
circumference toward the Foetal head. As a result of this
maneuver, images of the Foetal heart in the four-chamber
view should be obtained. At this point, it is very important to
make sure that the Foetal heart is situated in the middle of the
chest with the cardiac apex on the same side of the body as
the stomach. The Foetal heart should be without pronounced
deviation to either the right or left thorax, because this could
be an indication of a situs abnormality or other intra-thoracic
congenital malformations.16

The four-chamber view is useful to assess the relative
sizes of the cardiac chambers and to identify individual
chamber anatomy. On exclusion of dextrocardia, the most
posterior chamber closest to the spine is the left atrium with
the septum secundum flap within it, and the chamber closest
to the ventral abdominal wall is the right ventricle. In
addition, the right ventricle should have coarse muscular
trabeculations, including the moderator band visible toward
its apex, which appears to foreshorten the right ventricular
cavity. The chamber sizes at the level of the atrio-ventricular
valves should be equal in size. The walls of the ventricles
must be equal in size. Although, mild ventricular
disproportion can occur as a normal variant, hypoplastic left
heart syndrome and coarctation of aorta are important causes
of this disparity.17 The echogenicity of the tricuspid and the
mitral valve must be the same with the septal leaf of tricuspid
valve insertion noted to be slightly more apically displaced
than the left sided mitral valve. The valves should be noted to
open and close completely. The inter-ventricular septum must
be intact and the atrial septum must be intact except for the
opening of foramen ovale, and the septum secundum flap in
the left atrium should be seen coming and closing the
foramen ovale. The pulmonary veins should be seen entering
the left atrium. Whenever possible, it is important to see the
four-chamber view from more than one orientation, including
one that is perpendicular to the inter-ventricular septum,
because the upper portion of the septum may be quite thin in
normal foetuses, giving rise to a false-positive suspicion of a
ventricular septal defect.18 Some views may reveal a small
hypoechogenic rim around the Foetal heart that can be
mistaken for a pericardial effusion. An isolated finding of this
type usually represents a normal variation.19 Cardiac rate and
regular rhythm should be confirmed. The normal heart rate
ranges from 120-160 beats per minute. Mild bradycardia is
transiently observed in second trimester foetuses. Fixed
bradycardia of heart rate especially below 110 beats per
minute requires timely evaluation for possible heart block.
Mild tachycardia (> 160 beats per minute) can occur as a
normal variant during Foetal movement. Persistent
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tachycardia, however, should be further evaluated for either
possible Foetal distress or serious tachydysrhythmias.7

With the normal four-chamber view, conditions such
as endocardial cushion defects, large ventricular septal
defects, atrial septal defects, Ebstein's anomaly and left and
right hypoplastic heart syndrome could be excluded but for
outflow tract malformations, the long axis view of the left and
the right ventricle needs to be obtained. Following the fourchamber view, to get the long axis view, we rotate the
transducer towards the Foetal head. On this view, the anterior
wall of the aorta should be continuous with the interventricular septum without any breaks and the posterior wall
of the aorta should be continuous with the mitral valve; and
at the origin of the aorta, the atrio-ventricular valve must be
visualized opening and closing. This view is classified as a
five-chamber view. With this view, we can exclude high
membranous ventricular septal defects, tetralogy of fallots,
double outlet right ventricle, and transposition of great
vessels. By rotating and sliding the transducer further towards
the Foetal head, we should be able to obtain the view of the
aortic arch with descending aorta and the three neck vessels
originating from the apex of the aortic arch. After obtaining
the aortic arch, moving the transducer towards the anterior
abdominal wall slightly and tilting the transducer by 150, the
view of the right ventricle can be obtained with the
pulmonary trunk away from it and the ductus entering the
aorta forming the ductal arch. Within the pulmonary artery,
near its origin, the pulmonary valve should be visualized
opening and closing. Except for the distal one-third of
pulmonary artery, the remaining proximal two-third of
pulmonary trunk should be parallel to one another and the
pulmonary trunk and aorta should be equal in size in most
instances. With this view, pulmonary stenosis of moderate to
severe degree and pulmonary atresia would be excluded and
the transposition of great vessels would be definitely
excluded. The final view is to demonstrate the superior vena
cava and the inferior vena cava entering the right atrium.

The sensitivity of the above-mentioned detailed Foetal
echocardiographic examination at 22 weeks of gestation lies in
the region of 80% for high-risk as well as low-risk collectively
with a specificity approaching 100%.20 However, conditions
such as membranous coarctation of aorta, anomalous
pulmonary venous drainage, mild degree of stenosis of outflow
tract valves and the atrial and ventricular septal defects less
than 3 mm are the ones which are likely to be missed which
will not account for major morbidity or mortality by
themselves, however still elude prenatal diagnosis.
The additional use of colour Doppler imaging in the
segmented approach allows examination of the blood flow
across the respective connections and especially facilitates
identification of venous inflow and imaging of great arteries.
Therefore, two-dimensional and colour coded Doppler
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Foetal echocardiography as a screening tool:

Screening programme for prenatal diagnosis of CHD
using Foetal echocardiography is important as it allows not
only improved counseling of families after a prenatal
diagnosis of CHD, but also for proper perinatal and neonatal
management as the neonate with a significant cardiac lesion
will benefit from delivery at a tertiary care center where the
expertise of paediatric cardiologists and cardiac surgeons are
readily available21 as 50% of the congenital cardiac
anomalies are considered easily amenable to surgery.3 Also,
implementation of routinely offered Foetal echocardiography
would lead to early diagnosis so that the parents can be
informed about the severity and prognosis of the condition,
before viability is reached. This in turn would enable them to
make informed decisions about the further course of
pregnancy, for example, avoidance of caesarean section for a
lethal anomaly or continuation of pregnancy with delivery in
a tertiary center. It would also improve the chances of
survival of a baby with a critical congenital defect by
ensuring that the necessary prenatal and postnatal care is
provided.21 Precise knowledge of critical CHD can guide for
Foetal cardiac catheter-based interventions. Several
specialized centers offer catheter-based interventions in-utero
to dilate stenosis of the pulmonary or aortic valves.22 The risk
of aneuploidy associated with Foetal cardiac anomalies is
much greater (ranging between 13% - 33%) than that
associated with advanced maternal age.23,24 Knowledge of
the Foetal karyotype allows for well-defined postnatal
surgical intervention that may be altered by the finding of a
devastating aneuploidy diagnosis. Also, when available, it
provides an opportunity for thorough counseling regarding
reproductive options and the assessment of the recurrence
risk for future pregnancies.5 It should also be mentioned that
a negative Foetal echocardiography could provide required
reassurance to the family who had had a previous child with
a congenital heart defect.21 In addition, the examination is
safe and does not involve any invasive procedure.

Why the need for introducing Foetal
echocardiography as a screening tool at 18-22
weeks of gestation to general population?

Only 10 percent of the foetuses with cardiac
anomalies have identified risk factors, which includes family
history of CHD (previous affected child; parents), coexisting
maternal disease (e.g. type I diabetes mellitus, collagen
vascular disease, or phenylketonuria), exposure to teratogens
in early pregnancy such as lithium carbonate, retinoids,
phenytoin, carbamazapine, valproic acid, paroxetine,
infections such as parvovirus B19, rubella, coxsackie,
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autoimmune antibodies such as anti-Ro (SSA), anti-La
(SSB), hydrops, effusion, abnormal karyotype and
extracardiac Foetal anomalies such as diaphragmatic hernia,
exomphalos noted on a general Foetal sonogram. In such
cases, detailed Foetal echocardiography is commonly done as
part of the sonographic screening between 18 and 22 weeks
of gestation.25 However, most cases of CHD occur in
pregnancies with no prenatal risk factors.7 Hence, basing
referral for Foetal echocardiography on the presence of risk
factors only excludes about 85% of foetuses with severe
detectable heart defects from screening.26

Generally, detailed Foetal echocardiography is not
performed routinely for prenatal screening but is reserved for
cases which are at high-risk for CHD, as it is a time
consuming procedure that requires many two-dimensional
cross-sectional views of the heart, additional Doppler and
color flow investigations.25 Also, skilled investigators with
special experience in Foetal cardiology are needed.
Consequently, cardiac abnormalities are among the major
malformations that are most frequently missed in prenatal
ultrasound examinations which is a cause for concern because
undetected CHD increases the risk of early neonatal mortality.

Most of the centers use four-chamber view as a
screening modality for evaluation of the Foetal heart and
based on this view, vast majority of obstetricians develop a
suspicion of anomalies of the Foetal heart, thereby initiating
further detailed evaluation. However, four-chamber screening
alone is not adequate to identify important abnormalities of
the ventricular outflow tracts, great arteries and visceral and
atrial situs and results in the sensitivity for detection of
congenital cardiac anomalies to range between 5 and 60%.27
The four-chamber view only allows the examination of a
small aspect of the heart, namely the atria, the inter-atrial
septum with the valve of the foramen ovale beating into the
left atrium, both AV-valves which open and close, and the
inter-ventricular septum with the inflow tracts. Other lesions
in the region of the outflow tracts and the large vessels will
generally not be detectable via the four-chamber view,
including some severe anomalies which become
symptomatic early after birth (transposition of the great
arteries, tetralogy of fallot, pulmonary stenosis and atresia
with ventricular septal defect, double outlet right ventricle
and truncus arteriosus communis).
Multiple studies to date show that the detection rate of
cardiac anomalies can be markedly increased by 30% by
incorporating visualization of the outflow tracts and the great
arteries into the examination compared with using fourchamber view alone.18,25 Following the technical
improvements in ultrasonography in recent years, a
systematic review carried out in 2005, found Foetal
echocardiography close to 100% specific for diagnosing a
normal foetus among unselected and low risk populations.20
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In conclusion with this, the screening study reported by the
authors on 39,808 patients undergoing a thorough routine
two-dimensional Foetal echocardiography at 22 weeks of
gestation at the Antenatal Diagnostic Center of the National
University Hospital, Singapore, revealed sensitivity of 85.4%
for the detection of CHD and a specificity of 99.9% to rule
out any such anomalies. Our positive and negative predictive
rates were 87.7% and 99.9%, respectively.28

Can early Foetal echocardiography between 13
and 15 weeks of gestation be used for general
screening?

Though, the use of high resolution and high frequency
trans-vaginal combined with trans-abdominal transducers
between 13 and 15 weeks of gestation allows the
demonstration of all cardiac structures and the detection of
majority of cardiac defects,29-31 its sensitivity is only above
60% which, however, is 20% lower than that of the transabdominal examination at 18-22 weeks gestation.20 The
lesser resolution of early echocardiography in relation to the
small size of the Foetal heart may not always allow the
detection of ventricular septal defects, double outlet right
ventricle and tetralogy of fallot. The biggest disadvantage of
first trimester echocardiography is the delayed progression of
structural and functional cardiac changes in some forms of
heart disease, which may only manifest at a later gestational
age. Also, compared with trans-abdominal echocardiography
between 18-22 weeks gestation, early echocardiography is
less reliable and may result in a higher false-negative and
false-positive rate30-32 and needs to be supplemented by a
second examination between 18 and 22 weeks of gestation.
Furthermore, early echocardiography is more time
consuming and requires a high level of training of the
examiner. Therefore, it seems unjustified to use early Foetal
echocardiography for general screening. On the other hand, it
would be of great value to increase the examination quality in
second trimester cardiac scanning, which should be
performed by experienced examiners. This may allow the
detection of 80% of cardiac defects.

Role of early Foetal echocardiography in highrisk pregnancies:

It is now well known that cardiac defects are found in
increased frequency in the group of foetuses with thickened
nuchal translucency (NT) detected by screening between 11
and 14 weeks gestation.33-35 Thus, NT screening could help to
define a new high-risk group, which should receive a detailed
Foetal echocardiography at or before 14 weeks of gestation as
the risk of CHD is doubled over the background population if
the NT measurement is between 2.5 and 3.5 mm, increasing to
26 times the background rate if the nuchal measurement is
over 6.5 mm.36 First trimester Foetal echocardiography should
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also be offered to mothers at high risk of having children with
CHD, with one or more first-degree relatives with cardiac
defects37 or those in whom cardiac defects are either inherited
by mendelian rules alone, those with pre-gestational diabetes
or diabetes diagnosed in early pregnancy and as a part of an
early genetic sonogram service to women at-risk of
chromosomal abnormalities due to advanced maternal age
who have declined invasive testing. This should then be
followed up at 18-22 weeks of gestation as a follow-up scan.38

Future Developments:

Foetal echocardiography will play a big role as
another modality in the assessment of Foetal well being
besides multi-vessel Doppler studies, biophysical profile,
amniotic fluid index and cardiotocography because when the
foetus is in any kind of stress under conditions such as
hypoxia, anaemia, abruptio, intrauterine infection, and
preterm labour, cardiac output has to increase and in the
foetus it is reflected by the right atrium enlarging, as the
predominant side of the Foetal heart is the right chamber. The
M-mode assessment of the heart chambers, the tricuspid
ejection ratios and the precardiac load index obtained from
the inferior vena cava is all going to play a significant role in
the future in monitoring foetuses such as with intrauterine
growth-restriction, twin-twin transfusion syndrome and cases
of rhesus iso- immunization.

Team approach:

It is important to highlight that all members of the
prenatal and early postnatal health care team, including the
Foetal medicine specialist, geneticist, perinatalogist,
paediatrician, paediatric cardiologist and paediatric cardiac
surgeon work together to provide care as a team. A Foetal
Board comprising of the above mentioned multidisciplinary
members must be constituted so as to review each case of
Foetal malformation, refining the diagnosis, establishing
management plans, and facilitating issues relating to the
delivery of the patients. It is the authors' belief that the
concept of the team approach not only capitalizes on the
knowledge and expertise of the particular physicians in their
respective fields, but also broadens the teams' competence in
parental counseling as well as coordinating the planning of
the prenatal and postnatal management of the patient.

Conclusion

As nearly 90% of all pregnancies in which the foetus
has a cardiac abnormality are at no increased risk and as
routine prenatal ultrasound scans almost always miss an
isolated cardiac defect, appropriate detection of cardiac
abnormalities can only be achieved by carrying out routine
Foetal echocardiography in all foetuses in the second
trimester, irrespective of the presence or absence of risk
Vol. 61, No. 9, September 2011

factors for the development of congenital cardiac disease.

It must be remembered that Foetal echocardiography
requires the use of high quality ultrasound machines and, in
particular, the thorough training of the examiner. Therefore,
the full potential of Foetal echocardiographic screening can
only be reached with significant improvement in the level of
training of all personnel involved in screening and by
centralization of the examination in the second trimester.
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